REGIONAL OFFICE OF EDUCATION

whitePaper | December 27, 2021

Government Financial & Operational Management Special Report Identifying the challenges that face your governmental entity is oftentimes the first step in helping position your government for future success. Are you able to balance the needs of your community while efficiently managing and reporting on the services you’re charged with providing?

whitePaper | April 6, 2020

Government agencies are at an important crossroads. For years they’ve faced mandates to modernize IT, but many have made limited progress. Now, with increasing citizen demands and other mission requirements, agencies are under pressure to adopt newer technologies. Faced with aging systems that are not up to the task — along with the need to reduce security risks and improve efficiencies — cloud is emerging as the primary vehicle for transforming government agencies.

whitePaper | October 5, 2022

Cloud is helping to modernize government services and transform citizen interactions. But cloud security hasn’t kept up with the pace of cloud adoption. Ensuring a secure, compliant environment in the cloud is critical— particularly for public-sector organizations that collect, store and manage highly sensitive data on behalf of their citizens.

whitePaper | March 30, 2022

Why have we written disparaging statements about government when our firm is so deeply committed to public sector excellence? These include statements like “as the fire rages on, our governments seem powerless” and “hunches no longer pass for evidence these days, unless we’re talking about government policy.” We have compared the policy-making process to a chaotic game of tag and suggested that government policymakers can act as seemingly irrational as Cosmo Kramer did on Seinfeld.

whitePaper | June 1, 2022

we have seen progress made towards the creation of a fully functioning Digital ID marketplace by the UK Government with the publication by DCMS of the Alpha version 2 of the UK Digital Identity & Attributes Trust Framework2 in September 2021 following a lengthy period of consultation with - and substantive input from

whitePaper | February 12, 2020

Both the U.S. Government and biopharmaceutical industry have been central engines for developing new medical treatments and cures, thereby lowering the effective price of better health for patients worldwide. The sector has done so by being both the world leader in these biopharmaceutical cures and treatments as well as the source of the returns that are required to fund new medical R&D investments.